SCHEMBL9636199

SCHEMBL9636199

CC1CN(c2c(F)cc3c(=O)c(C(=O)O)cn(C4CC4)c3c2F)CCN1CCO

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 8/20 0.57
ALDH1A1 P00352 4/20 0.57
HPGD P15428 3/20 0.57
LMNA P02545 2/20 0.57
KCNH2 Q12809 5/20 0.56
POLB P06746 3/20 0.56
TDP1 Q9NUW8 3/20 0.56
OPRM1 P35372 2/20 0.56
PRKD3 O94806 1/20 0.56
ALOX15 P16050 1/20 0.56
CLK2 P49760 1/20 0.56
HSD17B10 Q99714 1/20 0.56
CLK4 Q9HAZ1 1/20 0.56
CHRM2 P08172 1/20 0.55
CHRM1 P11229 1/20 0.55
OPRD1 P41143 1/20 0.55
NPSR1 Q6W5P4 1/20 0.55
CYP2C19 P33261 1/20 0.52
L3MBTL1 Q9Y468 1/20 0.52
ATM Q13315 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9788091 0.95 KDM4E (0.55) KDM4EALDH1A1HPGDLMNAKCNH2
SCHEMBL10695206 0.92 ALDH1A1 (0.67) KDM4EALDH1A1HPGDLMNAKCNH2
SCHEMBL9636186 0.92 KDM4E (0.59) KDM4EALDH1A1HPGDLMNAKCNH2
SCHEMBL9635091 0.91 KDM4E (0.55) KDM4EALDH1A1HPGDLMNAKCNH2
SCHEMBL9636208 0.89 KDM4E (0.47) KDM4EALDH1A1HPGDLMNAKCNH2
SCHEMBL9634911 0.88 KDM4E (0.61) KDM4EALDH1A1HPGDLMNAKCNH2
SCHEMBL9634820 0.85 KCNH2 (0.58) KDM4EALDH1A1HPGDLMNAKCNH2
SCHEMBL6217062 0.84 ALDH1A1 (0.53) KDM4EALDH1A1HPGDLMNAKCNH2
SCHEMBL9703698 0.84 KDM4E (0.51) KDM4EALDH1A1HPGDLMNAKCNH2
SCHEMBL10695481 0.84 ALDH1A1 (0.70) KDM4EALDH1A1HPGDLMNAKCNH2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0337231-B1 I. M. INJECTION FORMS OF GYRASE-INHIBITORS BAYER AG (DE) 1992-06-17 EP disclosed
US-5023257-A Related to ciprofloxacin, in the form of oily suspension; bacterial infections BAYER AKTIENGESELLSCHAFT (DE) 1991-06-11 US disclosed
US-4952695-A Cyclopropyl-6,7,8-trifluoro-1,4-dihydro-4-oxo-3-quinoline carboxylic acid, intermediate for antibacterials BAYER AKTIENGESELLSCHAFT (DE) 1990-08-28 US disclosed
EP-0126355-B1 7-AMINO-1-CYCLOPROPYL-6,8-DIFLUORO-1,4-DIHYDRO-4-OXO-3-QUINOLINE-CARBOXYLIC ACID, PROCESSES FOR THEIR PREPARATION AND ANTIBACTERIAL AGENTS CONTAINING THEM BAYER AG (DE) 1987-09-09 EP disclosed
US-4556658-A 7-Amino-1-cyclopropyl-6,8-difluoro-1,4-dihydro-4-oxo-quinoline-3-carboxylic acids and antibacterial agents containing these compounds BAYER AKTIENGESELLSCHAFT (DE) 1985-12-03 US disclosed
EP-0126355-A1 7-Amino-1-cyclopropyl-6,8-difluoro-1,4-dihydro-4-oxo-3-quinoline-carboxylic acid, processes for their preparation and antibacterial agents containing them BAYER AG (DE) 1984-11-28 EP disclosed